| Company Name | Exchange | Ticker | Last Price | Total Analyst Coverage |
Upgrade/ Downgrade |
Analyst Name | Rating Company | Target Price |
Upside/ Downside (%) |
|---|---|---|---|---|---|---|---|---|---|
| Atlantic Power Corp | TSX | ATP | 3.82 | 461.0 | Upgrade to sector perform from underperform | Nelson Ng | RBC Capital Markets | 4.00 | 4.7% |
| Rubicon Minerals Corp | TSX | RMX | 1.53 | 555.5 | Initiate with outperform | Stephen Parsons | National Bank Financial | 1.85 | 20.9% |
| MAG Silver Corp | TSX | MAG | 11.20 | 675.2 | Initiate with speculative buy | Daniel Earle | TD Securities | 14.00 | 25.0% |
| Enerflex Ltd | TSX | EFX | 19.54 | 1,532.0 | Initiate with outperform | Dan Macdonald | RBC Capital Markets | 24.00 | 22.8% |
| Kivalliq Energy Corp | TSXV | KIV | 0.19 | 35.3 | Downgrade to market perform from outperform | David Sadowski | Raymond James | 0.30 | 62.2% |
RBC Capital Markets upgraded Atlantic Power Corp (TSX: ATP), engaged in operating a fleet of power generation and infrastructure assets, to sector perform from underperform increasing its price target to C$4.00 from C$3.00, indicating an upside of 4.7% from current levels.
Meanwhile, RBC initiated coverage on Enerflex Ltd (TSX: EFX), a Canada-based company which is a supplier for natural gas compression, oil and gas processing, refrigeration systems and power generation equipment plus in-house engineering and mechanical services, with an outperform rating assigning a 12-month price target of $24.00, indicating an upside of 22.8% from current levels.
Coverage on Rubicon Minerals Corp (TSX: RMX), a mineral exploration company engaged in the acquisition, exploration and development of gold and base-metal exploration properties, was initiated with an outperform rating at National Bank Financial assigning a 12-month price target of C$1.85, indicating an upside of 20.9% from current levels.
TD Securities initiated coverage on MAG Silver Corp (TSX: MAG), focused on advancing two projects located within the Mexican Silver Belt, with a speculative buy assigning a 12-month price target of C$14.00, indicating an upside of 25% from current levels.
Raymond James downgraded Kivalliq Energy Corp (TSXV: KIV), an exploration-stage company focused on the acquisition, exploration and development of resource properties, primarily uranium, to market perform from outperform lowering its price target to C$0.30 from C$0.50, indicating an upside of 62.2% from current levels.
| Company Name | Exchange | Ticker | Last Price |
Total Analyst Coverage |
Upgrade/ Downgrade |
Analyst Name | Rating Company | Target Price |
Upside/ Downside (%) |
|---|---|---|---|---|---|---|---|---|---|
| Covenant Transportation Group Inc | NASDAQ | CVTI | 12.32 | 181.9 | Upgrade to market outperform from market perform | Donald Broughton | Avondale Partners LLC | 14.50 | 17.7% |
| Amarin Corp PLC | NASDAQ | AMRN | 1.60 | 275.9 | Upgrade to buy from hold | Thomas Wei | Jefferies | 3.50 | 118.8% |
| AngioDynamics Inc | NASDAQ | ANGO | 16.00 | 566.7 | Upgrade to buy from hold | Jason R Mills | Canaccord Genuity Corp | 20.00 | 25.0% |
| Veracyte Inc | NASDAQ | VCYT | 15.06 | 318.9 | Initiate with overweight | William R Quirk | Piper Jaffray | 21.00 | 39.4% |
| Trulia Inc | NYSE | TRLA | 43.95 | 1,622.8 | Downgrade to sector perform from outperform | Mark S Mahaney | RBC Capital Markets | 45.00 | 2.4% |
Avondale Partners LLC upgraded Covenant Transportation Group Inc (NASDAQ: CVTI), a carrier for transportation companies, such as freights forwarders, less-than-truckload carriers, and third-party logistics providers, to market outperform from market perform increasing its price target to $14.50 from $12.00, indicating an upside of 17.7% from current levels.
Amarin Corp PLC (NASDAQ: AMRN), a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease, was upgraded to buy from hold at Jefferies with a price target of $3.50, indicating an upside of 118.8% from current levels.
Canaccord Genuity Corp upgraded AngioDynamics Inc (NASDAQ: ANGO), engaged in designing, manufacturing and selling a range of medical, surgical and diagnostic devices, to buy from hold increasing its price target to $20.00 from $16.25, indicating an upside of 25% from current levels.
Piper Jaffray initiated coverage on Veracyte Inc (NASDAQ: VCYT), a diagnostics company focused on molecular cytology, with an overweight rating assigning a 12-month price target of $21.00, indicating an upside of 39.4% from current levels.
RBC Capital Markets downgraded Trulia Inc (NYSE: TRLA), a real estate search engine company that offers free and subscription products that provide real estate professionals with access to transaction-ready consumers and help them enhance their online presence, to sector perform from outperform with a price target of $45.00, indicating an upside of 2.4% from current levels.
